MRSA Research Center

The University of Chicago Medicine






  • Welcome
  • Patients
  • Clinicians
  • Researchers
  • Education & Training
  • Alumni

For Clinical Researchers – Clinical References

2017

Bradley J, Glasser C, Patino H, Arnold SR, Arrieta A, Congeni B, Daum RS, Kojaoghlanian T, Yoon M, Anastasiou D, Wolf DJ, Bokesch P. Daptomycin for complicated skin infections: A randomized trial. Pediatrics. 2017 Feb 15. pii: e20162477.

Krezalek MA, Hyoju S, Zaborin A, Okafor E, Chandrasekar L, Bindokas V, Guyton K, Montgomery CP, Daum RS, Zaborina O, Boyle-Vavra S, Alverdy JC. Can methicillin-resistant Staphylococcus aureus silently travel from the gut to the wound and cause postoperative infection? Modeling the "Trojan Horse hypothesis". Annals of Surgery 2017 Feb 9.

Wilbur MB, Daum RS, Gold HS. CLINICAL DECISIONS. Skin abscess. New England Journal of Medicine 2016 Mar 3;374(9):882-4.

2016

David MZ. MRSA community pneumonia: a global perspective on resistance. Lancet Infectious Diseases 2016 Dec;16(12):1309-1310.

Mir-Sanchis I, Roman CA, Misiura A, Pigli YZ, Boyle-Vavra S, Rice PA. Staphylococcal SCCmec elements encode an active MCM-like helicase and thus may be replicative. Nature Structural and Molecular Biology 2016 Oct;23(10):891-898.

Greenberg JA, David MZ, Churpek MM, Pitrak DL, Hall JB, Kress JP. Sequential organ failure assessment score modified for recent infection in patients with hematologic malignant tumors and severe sepsis. American Journal of Critical Care 2016 Sep;25(5):409-17.

Ward MJ, Goncheva M, Richardson E, McAdam PR, Raftis E, Kearns A, Daum RS, David MZ, Lauderdale TL, Edwards GF, Nimmo GR, Coombs GW, Huijsdens X, Woolhouse ME, Fitzgerald JR. Identification of source and sink populations for the emergence and global spread of the East-Asia clone of community-associated MRSA. Genome Biology 2016 Jul 26;17(1):160.

Alegre ML, Chen L, David MZ, Bartman C, Boyle-Vavra S, Kumar N, Chong AS, Daum RS. Impact of Staphylococcus aureus USA300 colonization and skin infections on systemic immune responses in humans. Journal of Immunology 2016 Aug 15;197(4):1118-26.

Azarian T, Daum RS, Petty LA, Steinbeck JL, Yin Z, Nolan D, Boyle-Vavra S, Hanage WP, Salemi M, David MZ. Intrahost evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft-tissue infections. Journal of Infectious Diseases 2016 Sep 15;214(6):895-905.

Hemmige V, Lauderdale DS, David MZ. The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study. Epidemiology and Infection 2016 Oct;144(13):2889-98.

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J 4th, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. Journal of Clinical Virology 2016 Jul;80:12-9.

Charnot-Katsikas A, Baewer D, Cook L, David MZ. Fulminant hepatic failure attributed to infection with human herpesvirus 6 (HHV-6) in an immunocompetent woman: A case report and review of the literature. Journal of Clinical Virology 2016 Feb;75:27-32.

Greenberg JA, Hohmann SF, Hall JB, Kress JP, David MZ. Validation of a method to identify immunocompromised patients with severe sepsis in administrative databases. Annals of the American Thoracic Society 2016 Feb;13(2):253-8.

2015

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe influenza in 33 US hospitals, 2013-2014: Complications and risk factors for death in 507 patients. Infection Control and Hospital Epidemiology 2015 Nov;36(11):1251-60.

Gaupp R, Lei S, Reed JM, Peisker H, Boyle-Vavra S, Bayer AS, Bischoff M,
Herrmann M, Daum RS, Powers R, Somerville GA. Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype. Antimicrobial Agents and Chemotherapy. 2015 Jul;59(7):4226-38.

Miller LG, Daum RS, Chambers HF. Antibacterial treatment for uncomplicated
skin infections. New England Journal of Medicine. 2015 Jun 18;372(25):2460.

Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S,
Hoagland RJ, Chambers HF; DMID 07-0051 Team. Clindamycin versus
trimethoprim-sulfamethoxazole for uncomplicated skin infections. New England Journal of Medicine.
2015 Mar 19;372(12):1093-103.

Zhao F, Cheng BL, Boyle-Vavra S, Alegre ML, Daum RS, Chong AS, Montgomery CP. Proteomic identification of saeRS-dependent targets critical for protective humoral immunity against Staphylococcus aureus skin infection. Infection and Immunity. 2015 Sep;83(9):3712-21.

Hemmige V, McNulty M, Silverman E, David MZ. Recurrent skin and soft tissue
infections in HIV-infected patients during a 5-year period: incidence and risk
factors in a retrospective cohort study. BMC Infectious Diseases. 2015 Oct 26;15:455.

Morgan E, David MZ. Do citation trends reflect epidemiologic patterns? Assessing MRSA, emerging and re-emerging pathogens, 1963-2014. BMC Infectious Diseases. 2015 Oct 26;15:460.

Carrel M, Perencevich EN, David MZ. USA300 methicillin-resistant Staphylococcus aureus, United States, 2000-2013. Emerging Infectious Diseases. 2015 Nov;21(11):1973-80.

David MZ, Acree ME, Sieth JJ, Boxrud DJ, Dobbins G, Lynfield R, Boyle-Vavra S, Daum RS. Pediatric Staphylococcus aureus isolate genotypes and infections from the dawn of the community-associated methicillin-resistant S. aureus epidemic era in Chicago, 1994 to 1997. Journal of Clinical Microbiology. 2015 Aug;53(8):2486-91.

Montgomery CP, David MZ, Daum RS. Host factors that contribute to recurrent
staphylococcal skin infection. Current Opinion in Infectious Diseases. 2015 Jun;28(3):253-8.

Alam T, Reed T, Sieth J, Kumar N, Miller LG, Eells S, Boyle-Vavra S, Daum RS, David MZ. Whole genome sequencing demonstrates that MRSA USA300 is transmitted primarily in the household. mBio. 2015 Mar 10;6(2):e00054.

Boyle-Vavra S, Li X, Alam MT,  Read TD, Jean C. Lee JC, Sieth J, David MZ, Kumar N, Eells SJ, Miller LG, Dobbins G, Boxrud DJ, Chambers HF, Lynfield R, Daum RS. USA300 and USA500 lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. mBio. 2015 Apr 7;6(2). pii: e02585-14.

Kumar N, David MZ, Boyle-Vavra S, Sieth J, Daum RS. High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department. Journal of Clinical Microbiology. 2015 Mar;53(3):810-5.

Hemmige V, McNulty M, Silverman E, David MZ. Predictors of skin and soft
tissue infections in HIV-infected outpatients in the community-associated
methicillin-resistant Staphylococcus aureus era. European Journal of Clinical Microbiology and Infectious Diseases. 2015 Feb;34(2):339-47.

Miller LG, Eells SJ, David MZ, Ortiz N, Taylor AR, Kumar N, Cruz D,
Boyle-Vavra S, Daum RS. Staphylococcus aureus skin infection recurrences among household members: An examination of host, behavioral, and pathogen-level predictors. Clinical Infectious Diseases. 2015 Mar 1;60(5):753-63.

2014
Jones MB, Montgomery CP, Boyle-Vavra S, Shatzkes K, Maybank R, Frank BC,
Peterson SN, Daum RS. Genomic and transcriptomic differences in community
acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains. BMC Genomics. 2014 Dec 19;15(1):1145.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Porsa E, Schumm LP, Boyle-Vavra S, Daum RS. A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail. Infection Control and Hospital Epidemiology. 2014 Dec;35(12):1466-73.

Eells SJ, David MZ, Taylor A, Ortiz N, Kumar N, Sieth J, Boyle-Vavra S, Daum
RS, Miller LG. Persistent environmental contamination with USA300
methicillin-resistant Staphylococcus aureus and other pathogenic strain types in
households with S. aureus skin infections. Infection Control and Hospital Epidemiology. 2014
Nov;35(11):1373-82.

Wilder JR, Wegener DT, David MZ, Macal C, Daum R, Lauderdale DS. A national survey of skin infections, care behaviors and MRSA knowledge in the United States. PLoS One. 2014 Aug 19;9(8):e104277.

David MZ, Siegel JD, Henderson J, Leos G, Lo K, Iwuora J, Taylor AR, Zychowski DL, Porsa E, Boyle-Vavra S, Daum RS. Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees. Journal of Clinical Microbiology. 2014 Sep;52(9):3422-5.

Macal CM, North MJ, Collier N, Dukic VM, Wegener DT, David MZ, Daum RS, Schumm P, Evans JA, Wilder JR, Miller LG, Eells SJ, Lauderdale DS. Modeling the transmission of community-associated methicillin-resistant Staphylococcus aureus: a dynamic agent-based simulation. Journal of Translational Medicine. 2014 May 12;12:124.

David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG Jr, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth JJ, Volinski J, Spellberg B. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clinical Infectious Diseases. 2014 Sep 15;59(6):798-807.

Greenberg JA, David MZ, Pitrak DL, Hall JB, Kress JP. Prior infections are
associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies. European Journal of Clinical Microbiology and Infectious Diseases. 2014 Sep;33(9):1615-21.

Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG Jr. Antibacterial resistance leadership group: open for business. Clinical Infectious Diseases. 2014 Jun;58(11):1571-6.

Montgomery CP, Daniels M, Zhao F, Alegre ML, Chong AS, Daum RS. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infection and Immunity. 2014 May;82(5):2125-34.

Larsen J, David MZ, Vos MC, Coombs GW, Grundmann H, Harbarth S, Voss A, Skov RL. Preventing the introduction of methicillin-resistant Staphylococcus aureus into hospitals. Journal of Global Antimicrobial Resistance. 2014;2(4):260-8.

David MZ, Cadilla A, Boyle-Vavra S, Daum RS. Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008. PLoS One. 2014 Apr 22;9(4):e92760.

Greenberg JA, David MZ, Hall JB, Kress JP. Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality. PLoS One. 2014 Feb 5;9(2):e88197.

David MZ, Daum RS. Applying a new technology to an old question: whole-genome sequencing and Staphylococcus aureus acquisition in an intensive care unit. Clinical Infectious Diseases. 2014 Mar;58(5):619-21.

Qureshi NK, Yin S, Boyle-Vavra S. The role of the staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus. PLoS One 2014 Jan 15;9(1):e85873.

2013
David MZ, Daum RS. Update on epidemiology and treatment of MRSA Infections in children. Current Pediatric Reports . 2013 Sep 1;1(3):170-181.

David MZ, Siegel J, Lowy FD, Zychowski D, Taylor A, Lee CJ, Boyle-Vavra S,
Daum RS. Asymptomatic carriage of sequence type 398, spa type t571
methicillin-susceptible Staphylococcus aureus in an urban jail: a newly emerging,
transmissible pathogenic strain. Journal of Clinical Microbiology. 2013 Jul;51(7):2443-7.

Montgomery CP, Daniels MD, Zhao F, Spellberg B, Chong AS, Daum RS. Local
inflammation exacerbates the severity of Staphylococcus aureus skin infection.
PLoS One. 2013 Jul 5;8(7):e69508.

Misiura A, Pigli YZ, Boyle-Vavra S, Daum RS, Boocock MR, Rice PA. Roles of two large serine recombinases in mobilizing the methicillin-resistance cassette
SCCmec. Molecular Microbiology . 2013 Jun;88(6):1218-29.

Dukic VM, Lauderdale DS, Wilder J, Daum RS, David MZ. Epidemics of
community-associated methicillin-resistant Staphylococcus aureus in the United
States: a meta-analysis. PLoS One. 2013;8(1):e52722.

David MZ, Taylor A, Lynfield R, Boxrud DJ, Short G, Zychowski D, Boyle-Vavra
S, Daum RS. Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isolates at a U.S. Medical Center. Journal of Clinical Microbiology. 2013 Mar;51(3):814-9.

David MZ, Daum RS. Reply to Lewis et al. Infection Control and Hospital Epidemiology. 2013 Jan;34(1):106-7.

Lee BY, Singh A, David MZ, Bartsch SM, Slayton RB, Huang SS, Zimmer SM,
Potter MA, Macal CM, Lauderdale DS, Miller LG, Daum RS. The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clinical Microbiology and Infection. 2013 Jun;19(6):528-36.

Boyle-Vavra S, Yin S, Jo DS, Montgomery CP, Daum RS. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2013 Jan;57(1):83-95.

2012

Dukic VM, Lauderdale DS, Wilder J, Daum RS, David MZ. Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis. PLoS ONE. 2013;8(1):e52722.

Ito T, Hiramatsu K, Tomasz A, de Lencastre H, Perreten V, Holden MT, Coleman DC, Goering R, Giffard PM, Skov RL, Zhang K, Westh H, O'Brien F, Tenover FC, Oliveira DC, Boyle-Vavra S, Laurent F, Kearns AM, Kreiswirth B, Ko KS, Grundmann H, Sollid JE, John JF Jr, Daum R, Soderquist B, Buist G; International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Guidelines for reporting novel mecA gene homologues. Antimicrobial Agents and Chemotherapy 2012 Oct;56(10):4997-9.

Miller LG, Eells SJ, Taylor AR, David MZ, Ortiz N, Zychowski D, Kumar N, Cruz D, Boyle-Vavra S, Daum RS. Staphylococcus aureus colonization among household contacts of patients with skin infections: Risk factors, strain discordance, and complex ecology. Clinical Infectious Diseases 2012 Jun;54(11):1523-1535.

David MZ, Medvedev S, Hohmann S, Ewigman B, Daum RS. Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers. Infection Control and Hospital Epidemiology 2012;33(8).

Lee BY, Singh A, David MZ, McGlone SM, Bailey RR, Huang SS, Zimmer SM, Potter MA, Macal CM, Lauderdale DL, Miller LG, Daum RS. ;The economic burden of community associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clinical Microbiology and Infection. 2013 Jun;19(6):528-36.

Watkins RR, David MZ, Salata RA. Current concepts on the virulence mechanisms of methicillin-resistant Staphylococcus aureus. Journal of Medical Microbiology. 2012 Sep;61(Pt 9):1179-93.

Skov R, Christiansen K, Dancer SJ, Daum RS, Dryden M, Huang YC, Lowy FD. Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). International Journal of Antimicrobial Agents 2012 Mar;39(3):193-200.

David MZ, Rudolph KM, Hennessey TB, Zychowski DL, Asthi K, Boyle-Vavra S, Daum RS. MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006. Emerging Infectious Diseases 2012;18:105-8.

Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, Peters G. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. International Journal of Antimicrobial Agents 2012 Feb;39(2):96-104.

Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clincal Infectious Diseases 2012 Feb;54(4):560-7.

2011

Myers PJ, Marcinak J, David MZ, Zychowski DL, Boyle-Vavra S, Weber S, Daum RS. Universal admission screening for methicillin-resistant Staphylococcus aureus (MRSA) in a level IIID neonatal intensive care unit (NICU): the first 9 months. Infection Control and Hospital Epidemiology 2011;32:398-400.

David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: A possible reversal of roles? PLoS One. 2011 Apr 13;6(4):e18217

Dukic VM, David MZ, Lauderdale DS. Internet queries and MRSA surveillance. Emerging Infectious Diseases. 2011;17(6):1068-1070.

Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the Midwestern United States. Journal of Clinical Microbiology. 2011 Jan;49(1):95-100.

2010

Boyle-Vavra S, Daum RS. Reliability of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) assay in detecting MRSA isolates with a variety of genotypes from the United States and Taiwan. Journal of Clinical Microbiology 2010. Dec;48(12):4546-51.

David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical Microbiology Reviews. 2010 Jul;23(3):616-87.

Hoehn KS, Capouya JD, Daum RS, Glikman D, Gossett JG, Hafzalah M, Johnson D, Marcinak J. Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatric Critical Care Medicine. 2010;11(3):e32-35.

Macario E, Daum RS, Eells SJ, Miller LG. Using cognitive interviews to refine a household contacts survey on the epidemiology of community-associated methicillin resistant Staphylococcus aureus. Journal of Infection Prevention 2010;11(2):44-48.

2009

Daum RS. Epidemic Community Associated Methicillin Resistant Staphylococcus aureus Infections. Increasingly, Everyone's Problem. J AAPOS. 2009, 13:225-6.

Crawford SE, David MZ, Glikman D, King KJ, Boyle-Vavra S, Daum RS. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Journal of the American Board of Family Medicine 2009;22:647-654.

Burman W, Daum R. Grinding to a halt: The effects of the increasing regulatory burden on research and quality improvement efforts. Clinical Infectious Diseases 2009;49:328-335.

2008

David MZ, Rudolph KM, Hennessey TB, Boyle-Vavra S, Daum RS. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in rural southwest Alaska. Emerging Infectious Diseases. 2008;14(11):1693-9.

Daum RS. Removing the Golden Coat of Staphylococcus aureus. New England Journal of Medicine (Clinical Implications of Basic Research) 2008;359:85-87.

Crawford SE, Daum RS. Bacterial pneumonia, lung abscess, and empyema. In Taussig LM, Landau LI, Le Souef PN, Morgan WJ, Martinez FD, Sly PD. Pediatric Respiratory Medicine, Mosby Elsevier, Philadelphia, Pa, 2008, pp 501-554.

Daum RS.  Staphylococcus aureus vaccines.  In Plotkin S, Orenstein W, Offit P.  Vaccines, 5th edition, 2008, pp 1307-1315.

David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates.  Journal of Clinical Microbiology 2008;46:3222-3227.

David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS.  What is community-associated methicillin-resistant Staphylococcus aureusJournal of Infectious Diseases 2008;197:1235-1243.

Glikman D, Siegel JD, David MZ, Okuro NM, Boyle-Vavra S, Dowell ML, Daum RS.  Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from children with cystic fibrosis in the era of epidemic community-associated MRSA. Chest 2008;133:1381-1387.

Lowell G, Daum RS. Staphylococcus aureus infections. In Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases, 3rd edition, 2008, pp 679-693.

2007

Daum RS. The treatment of community-associated methicillin-resistant Staphylococcus aureus infections. New England Journal of Medicine2007;357:380-390.

Maree C, Daum RS, Boyle-Vavra, Miller LG.  A rapid increase in "community-associated" methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated Infections.  Emerging Infectious Diseases 2007;13:236-242.

2006

Crawford S, Boyle-Vavra S, Daum RS.  Community associated methicillin-resistant Staphylococcus aureus.  In Scheld M, Hooper D, Hughes JM, eds. Emerging Infections 7, 2006, pp 153-170.

Crawford SE, Daum RS. Therapy of staphylococcal infections.  In Burg, Ingelfinger J, Polin, Gershon A.  Current Pediatric Therapy, 18th edition, in press, 2006.

David MZ, Crawford SE, Boyle-Vavra S, Kim DC, Daum RS.  Comparing antibiotic resistance among community-associated methicillin-resistant Staphylococcus aureus isolates from adults and children.  Emerging Infectious Diseases 2006;12:631-637.

Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA and Participants in the Centers for Disease Control and Prevention-Convened Experts’ Meeting on Management of MRSA in the Community (RS Daum, Participating author), 2006. Available at http://www/cdc/gov/ncidod/dhqp/ar-mrsa-ca.html.

2005

Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, Boyle-Vavra S, Daum RS.  Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children.  New England Journal of Medicine 2005;353:1245-1251.

Crawford SE, Daum RS.  Epidemic community-associated methicillin-resistant Staphylococcus aureus: modern times for an ancient pathogen.  Pediatric Infectious Diseases 2005;24:459-460.

Mongkolrattanothai K, Daum RS.  Impact of community-associated methicillin-resistant Staphylococcus aureus on management of skin and soft tissue infections in children.  Current Infectious Diseases Reports 2005;7:381-389.

2004

Gregerson A, Daum RS. Staphylococcus aureus Vaccine.  In Plotkin SA, Orenstein WA (eds), Vaccines. 4th edition.  WB Saunders Co, Philadelphia, 2004. pp 1347–1355.

2003

Seal JB, Moreira B, Bethel CD, Daum RS.  Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: 15-year longitudinal assessment in a large university-based hospital.  Infection Control and Hospital Epidemiology 2003;42:403-408.

2001

Daum RS, Seal J.  Evolving antimicrobial therapy for Staphylococcus aureus infections: our backs to the wall.  Critical Care Medicine 2001;29:N92-N96 (suppl).

Hussain FM, Boyle-Vavra S, Daum RS.  Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic.  Pediatric Infectious Disease Journal 2001;20:763-767.

2000

Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS.  Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.  Pediatric Infectious Disease Journal 2000;19:1163-1166.

Lin PL, Oram RJ, Lauderdale D. Dean R, Daum RS.  Knowledge of CDC guidelines for the use of vancomycin in a large tertiary care children’s hospital.  Journal of Pediatrics 2000;137:694-700.

1999

Jain A, Daum RS.  Staphylococcal infections in children. Part 1.  Pediatrics in Review 1999;20:183-191.

Jain A, Ben-Ami T, Daum RS.  Staphylococcal infections in children. Part 2.  Pediatrics in Review 1999;20:219-227.

Jain A, Daum RS.  Staphylococcal infections in children. Part 3.  Pediatrics in Review 1999;20:261-265.

Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS.  Methicillin resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors.  Pediatric Infectious Disease Journal 1999;18:410-414.

1998

Daum RS.  Community-acquired methicillin-resistant Staphylococcus aureus infections in children.  Pediatric Infectious Disease Journal 1998;17:745-746.

Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS.  Community acquired methicillin resistant Staphylococcus aureus infections in children without traditional risk factors for infection.  Journal of the American Medical Association 1998;279:593-598.

1997

Maranan M, Moreira B, Boyle-Vavra S, Daum RS.  Antimicrobial resistance in the staphylococci.  Molecular mechanisms, epidemiology and clinical relevance.  Infectious Diseases Clinics of North America 1997;11:813-849.

1995

Moreira B, Daum RS.  Antibiotic resistance in the staphylococci.  Pediatric Clinics of North America 1995;42:619-648.